Minimal Invasive Surgery Devices Market Report 2026

Minimal Invasive Surgery Devices Market Overview

• Minimal Invasive Surgery Devices market size has reached to $36.61 billion in 2025 • Expected to grow to $50.02 billion in 2030 at a compound annual growth rate (CAGR) of 8.1% • Growth Driver: Rising Patient Awareness Fuels Growth Of Minimally Invasive Surgery Devices Market • Market Trend: Innovative Products Transform The Landscape Of Minimally Invasive Surgery • North America was the largest region in 2025 and Western Europe is the fastest growing region.

What Is Covered Under Minimal Invasive Surgery Devices Market?

Minimally invasive surgery devices are surgical tools that require fewer incisions of a smaller size or have a quicker healing process. A minimally invasive medical device is implanted inside the patient during surgery. The main product types of minimally invasive surgery devices are handheld instruments, inflation devices, cutter instruments, guiding devices, electrosurgical devices, auxiliary devices, and monitoring and visualization devices. Electrosurgical devices are used to destroy tissue, incise tissue, and control bleeding by coagulating blood. The various applications of minimal invasive surgery devices are laparoscopy, cardiovascular, cosmetic surgery, orthopedic surgery, obstetrics and gynecology, ophthalmology, neurosurgery, urology, and others that are used by end-users such as hospitals, ambulatory surgical centers (ASCS), and research institutes.

What Is The Minimal Invasive Surgery Devices Market Growth Forecast?

The minimal invasive surgery devices market size is expected to see strong growth in the next few years. It will grow to $50.02 billion in 2030 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to expansion of ambulatory surgical centers, rising geriatric population, demand for faster recovery procedures, advancements in surgical imaging, increasing healthcare expenditure. Major trends in the forecast period include growth in robot-assisted minimally invasive procedures, rising adoption of single-use surgical instruments, increasing demand for shorter hospital stays, expansion of day-care and outpatient surgeries, technological advancements in visualization devices.

Global Minimal Invasive Surgery Devices Market Segmentation

1) By Product Type: Handheld Instruments, Inflation Devices, Cutter Instruments, Guiding Devices, Electrosurgical Devices, Auxiliary Devices, Monitoring And Visualization Devices 2) By Application: Laparoscopy, Cardiovascular, Cosmetic Surgery, Orthopedic Surgery, Obstetrics And Gynecology, Ophthalmology, Neurosurgery, Urology, Other Applications 3) By End Users: Hospitals, Ambulatory Surgical Centers (ASCS), Research Institutes Subsegments: 1) By Handheld Instruments: Scissors, Forceps, Graspers 2) By Inflation Devices: Balloon Inflation Devices, CO2 Insufflators 3) By Cutter Instruments: Mechanical Cutters, Energy-based Cutters 4) By Guiding Devices: Guidewires, Sheaths 5) By Electrosurgical Devices: Electrosurgical Generators, Electrosurgical Pencil 6) By Auxiliary Devices: Suction Devices, Irrigation Devices 7) By Monitoring And Visualization Devices: Cameras, Monitors, Imaging Systems

What Are The Drivers Of The Minimal Invasive Surgery Devices Market?

The increasing awareness for minimally invasive surgeries among people is driving the minimally invasive surgery devices market. The minimally invasive surgeries require less/tiny cuts in the skin as compared to traditional surgical methods and aid in lesser pain, short hospital stay, less scarring, minimized chances of bleeding and infections, and low tissue damage. For instance, in June 2024, according to the American Society of Plastic Surgeons (ASPS), a US-based non-profit professional society, in 2023, minimally invasive procedures grew by 7%, exceeding surgical procedures by 2%. Thus, the growing demand for minimally invasive surgery (MIS) will increase the demand for the minimally invasive surgical devices market. The growing prevalence of chronic diseases is expected to drive the minimally invasive surgery market going forward. Chronic diseases are long-lasting health conditions that typically persist for three months or longer and can significantly affect a person's quality of life. The increase in chronic diseases is driven by factors like an aging population, poor lifestyle habits, and higher rates of obesity. Minimally invasive surgery aids in managing chronic diseases by providing safer, less painful treatment alternatives that lead to quicker recovery and fewer complications. For instance, in February 2024, according to the World Health Organization, a Switzerland-based agency of the United Nations, it is projected that over 35 million new cancer cases will arise by 2050, marking a 77% increase compared to the estimated 20 million cases in 2022. Therefore, the growing prevalence of chronic diseases is driving the minimally invasive surgery market in the forecast period.

Key Players In The Global Minimal Invasive Surgery Devices Market

Major companies operating in the minimal invasive surgery devices market are Abbott Laboratories, GE Healthcare, Medtronic plc, Siemens Healthineers, Smith & Nephew Plc., Stryker Corporation, Boston Scientific Corporation, EthiconInc., B. Braun Melsungen Ag, Conmed Corporation, Microline SurgicalInc., Zimmer Biomet HoldingsInc., Aesculap Inc., Koninklijke Philips NV, Cardinal Health inc., Danaher Corporation, KARL STORZ SE & Co. KG, Richard Wolf GmbH, Cook Medical, Intuitive Surgical Inc., Smiths Medical, Teleflex Incorporated, Terumo Corporation, Merit Medical Systems, AngioDynamics, MicroPort Scientific Corporation, Lumenis

Global Minimal Invasive Surgery Devices Market Trends and Insights

Major companies operating in the minimally invasive surgery market are focused on developing innovative products such as microrobotic tool to strengthen their position and gain a competitive advantage. The microrobotic tool is a robotic hand that acts as a surgeon’s hand while performing surgeries. For instance, in June 2023, according to Technology Org, a Germany-based website that provides science and technology news, a team of University of Toronto researchers developed a tiny robotic hand for minimally invasive brain surgery. The microrobotic tool is operated by an electromagnetic system. The microrobotic device enables surgeons to access hard-to-reach areas of the brain with minimal invasiveness, promising faster treatment and recovery for patients.

Regional Outlook

North America was the largest region in the minimally invasive surgery devices market in 2025. Western Europe was the second-largest region in the global minimally invasive surgery devices market analysis. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Minimal Invasive Surgery Devices Market?

The minimally invasive surgery devices market consists of sales of graspers, retractors/elevators, dilators, suturing instruments, laparoscopes, gastroscope, cystoscope, and ureteroscop. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.